New HIV Vaccine Candidate Shows Promise In Early Trials

A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.

Related Keywords

Bartonf Haynes , Wilton Williams , Duke Human Vaccine Institute , Duke Department Of Surgery , Candidate Shows Promise In Early Trials ,